Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-030513

Chief Development Officer acquired 1,844 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Guyer William Chief Development Officer 2022-09-01 Grant or award +922 $25.98 $23,954 922 D
Guyer William Chief Development Officer 2022-09-01 Grant or award +922 1,844 D
Loading xslF345X03/doc4.xml…